These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

631 related items for PubMed ID: 31513475

  • 1. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Khatlani K, Njike V, Costales VC.
    Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
    [Abstract] [Full Text] [Related]

  • 2. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, Laven JSE, Roeters van Lennep JE, Roseboom TJ, Hoek A.
    Hum Reprod Update; 2020 Nov 01; 26(6):942-960. PubMed ID: 32995872
    [Abstract] [Full Text] [Related]

  • 3. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    J Clin Endocrinol Metab; 2008 Sep 01; 93(9):3373-80. PubMed ID: 18583464
    [Abstract] [Full Text] [Related]

  • 4. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.
    Clin Endocrinol (Oxf); 2014 Mar 01; 80(3):432-8. PubMed ID: 23909452
    [Abstract] [Full Text] [Related]

  • 5. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
    Wang A, Mo T, Li Q, Shen C, Liu M.
    Endocrine; 2019 May 01; 64(2):220-232. PubMed ID: 30911997
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L, Lv S, Li F, Yu X, Bai E, Yang X.
    Front Endocrinol (Lausanne); 2020 May 01; 11():171. PubMed ID: 32296394
    [Abstract] [Full Text] [Related]

  • 7. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ.
    Hum Reprod Update; 2015 May 01; 21(5):560-74. PubMed ID: 26060208
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS.
    Fertil Steril; 2014 Nov 01; 102(5):1444-1451.e3. PubMed ID: 25239303
    [Abstract] [Full Text] [Related]

  • 9. Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.
    Dokras A, Playford M, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Sarwer DB, Allison KC, Coutifaris C, Mehta N, Legro RS.
    Clin Endocrinol (Oxf); 2017 May 01; 86(5):739-746. PubMed ID: 28199736
    [Abstract] [Full Text] [Related]

  • 10. Effects of Dietary Glycemic Index and Glycemic Load on Cardiometabolic and Reproductive Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Kazemi M, Hadi A, Pierson RA, Lujan ME, Zello GA, Chilibeck PD.
    Adv Nutr; 2021 Feb 01; 12(1):161-178. PubMed ID: 32805007
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
    Mehrabani HH, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F.
    J Am Coll Nutr; 2012 Apr 01; 31(2):117-25. PubMed ID: 22855917
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M, Arata-Bellabarba G, Valeri L, Velázquez-Maldonado E.
    Endocrinol Nutr; 2009 Feb 01; 56(2):59-65. PubMed ID: 19627713
    [Abstract] [Full Text] [Related]

  • 13. Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.
    Dietz de Loos A, Jiskoot G, Beerthuizen A, Busschbach J, Laven J.
    Eur J Endocrinol; 2021 Nov 30; 186(1):53-64. PubMed ID: 34714771
    [Abstract] [Full Text] [Related]

  • 14. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan 30; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

  • 15. Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome.
    Soares NP, Santos AC, Costa EC, Azevedo GD, Damasceno DC, Fayh AP, Lemos TM.
    Ann Nutr Metab; 2016 Jan 30; 68(3):220-7. PubMed ID: 27073909
    [Abstract] [Full Text] [Related]

  • 16. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May 30; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 17. Lifestyle interventions in women with polycystic ovary syndrome: A scoping systematic review of randomised evidence.
    H Al Wattar B, M Hussain N, S Khan K.
    Semergen; 2022 Apr 30; 48(3):186-194. PubMed ID: 35153107
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ, Hutchison SK, Norman RJ, Teede HJ.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD007506. PubMed ID: 21735412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.